Funding

Converge Bio

United States · AI · Biotech

AI platform for accelerated drug discovery and development

Visit converge-bio.comFunding history

Funding history

1 round · 1 with disclosed amounts
AnnouncedRoundAmountInvestors
Series A$25MBessemer Venture Partners — Role not disclosedSaras Capital — Role not disclosedTLV Partners — Role not disclosedVintage Investment Partners — Role not disclosed

Investors

Bessemer Venture PartnersSeries ASaras CapitalSeries ATLV PartnersSeries AVintage Investment PartnersSeries A

Coverage

Jan 13, 2026Converge Bio · Series A

Similar companies

Fairy DevicesTokyo company developing wearable devices and remote-assistance software for industrial field workers.Undisclosed · JICN equity investment
Guoke Brain-ComputerBeijing startup developing non-invasive wearable brain-computer interfaces that combine brain-signal detection, decoding and neural modulation.Undisclosed · Seed
Knowledge WorkTokyo software company developing sales AI agents, an agent operating platform and consulting services for enterprise sales teams.¥4.8B · Series C debt second close
Sourcesconverge-bio.com ↗